English  |  正體中文  |  简体中文  |  总笔数 :2856704  
造访人次 :  53794625    在线人数 :  1482
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"yu j j"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 1-10 / 48 (共5页)
1 2 3 4 5 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-09-14T01:29:28Z Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan Yang T.-H.; Fang Y.-J.; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN
臺大學術典藏 2022-09-07T06:49:46Z 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; YI-CHIA LEE; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-09-07T06:49:39Z Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; YI-CHIA LEE; Liou, J.-M.; Wu, M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-09-07T06:49:33Z Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis Chen M.-J.; Bair M.-J.; Chen P.-Y.; Lee J.-Y.; Yang T.-H.; Fang Y.-J.; Chen C.-C.; Chang A.-T.; Hsiao W.-D.; Yu J.-J.; Kuo C.-C.; Chiu M.-C.; Lin K.-P.; Tsai M.-H.; Hsu Y.-C.; Chou C.-K.; Chen C.-Y.; Lin J.-T.; YI-CHIA LEE; Wu M.-S.; Liou J.-M.; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-23T02:12:23Z Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-23T02:12:22Z Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan Yang T.-H.; Fang Y.-J.; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN
臺大學術典藏 2022-02-22T05:34:12Z Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-22T05:34:12Z Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan Yang T.-H.; Fang Y.-J.; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN
臺大學術典藏 2022-02-18T08:26:02Z 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial Liou J.-M.; CHIEH-CHANG CHEN; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2022-02-18T08:25:58Z Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H.

显示项目 1-10 / 48 (共5页)
1 2 3 4 5 > >>
每页显示[10|25|50]项目